Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.06 USD | +4.33% |
|
+1.40% | -18.79% |
05-03 | UBS Adjusts Price Target on InMode to $20 From $26, Maintains Neutral Rating | MT |
05-02 | InMode Shares Rise; Q1 Non-GAAP Earnings, Revenue Fall; 2024 Guidance Cut | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.79% | 1.53B | |
+3.77% | 210B | |
+8.83% | 186B | |
+31.94% | 158B | |
+33.19% | 113B | |
+4.52% | 66.13B | |
+22.41% | 56.25B | |
+1.34% | 49B | |
-5.92% | 38.16B | |
+1.94% | 35.98B |
- Stock Market
- Equities
- INMD Stock
- News InMode Ltd.
- Transcript : InMode Ltd. Presents at Barclays Global Healthcare Conference 2022, Mar-17-2022 09